Haemonetics (HAE) Inventory (2010 - 2026)

Haemonetics' Inventory history runs 17 years deep, the most recent figure standing at $306.4 million for Q1 2026.

• On a quarterly basis, Inventory fell 16.1% year-over-year to $306.4 million in Q1 2026; TTM through Mar 2026 was $306.4 million, a 16.1% decrease from a year earlier, with the FY2026 full-year figure at $306.4 million, down 16.1% from the prior year.
• Inventory retreated to $306.4 million in Q1 2026 per HAE's latest filing, from $321.2 million in the prior quarter.
• Across five years, Inventory topped out at $382.1 million in Q3 2024 and bottomed at -$26.4 million in Q4 2024.
• The 5-year median for Inventory is $304.9 million (2022), against an average of $292.3 million.
• Across the five-year window, Inventory plunged 108.68% in 2024 and jumped 1316.61% in 2025, its largest moves.
• Year by year, Inventory stood at $255.8 million in 2022, then grew by 18.87% to $304.0 million in 2023, then plunged by 108.68% to -$26.4 million in 2024, then soared by 1316.61% to $321.2 million in 2025, then decreased by 4.61% to $306.4 million in 2026.
• Per Business Quant, the three latest HAE Inventory figures stand at $306.4 million (Q1 2026), $321.2 million (Q4 2025), and $336.2 million (Q3 2025).